News, Deals & Cases

  • Rights Offering of Cavotec SA

    On 10 January 2019, Cavotec SA completed a capital increase by way of a rights offering to its shareholders in the amount of approximately CHF 22.4 million. The Cavotec group, with its Swiss holding company listed on Nasdaq Stockholm, is a leading engineering group that designs and manufactures automated connection and electrification systems for ports,…


    Read more: Rights Offering of Cavotec SA
  • Acquisition of Medpex’s e-commerce activities by Zur Rose Group

    On 18 October 2018, Zur Rose Group AG, Europe’s leading e-commerce pharmacy which is listed on SIX Swiss Exchange, announced that it is acquiring the e-commerce activities of Germany’s third largest online pharmacy medpex. The transaction was subject to regulatory clearances and closed on 4 January 2019.


    Read more: Acquisition of Medpex’s e-commerce activities by Zur Rose Group
  • Santhera Pharmaceuticals Holding Placement of Shares

    Santhera Pharmaceuticals Holding AG (Santhera) placed 3,133,334 new shares at an offer price of CHF 7.50 per share. The shares were placed by way of an accelerated bookbuilding procedure in a public offering in Switzerland, in private placements outside of the United States and Switzerland and in private placements within the United States to qualified…


    Read more: Santhera Pharmaceuticals Holding Placement of Shares
  • Rights Offering of Kuros Biosciences

    On 18 December 2018, Kuros Biosciences, a life science company focusing on the development and marketing of orthobiologics, completed a capital increase by way of a rights offering to its shareholders in the amount of approximately CHF 16.1 million. 34.6% of the shareholders of Kuros Biosciences exercised their subscription rights in the rights offering. The…


    Read more: Rights Offering of Kuros Biosciences
  • ARYZTA completed a rights offering in the amount of approximately CHF 900 million

    On 19 November 2018, ARYZTA, a global food business with a leadership position in speciality bakery, completed a capital increase by way of a rights offering structured as a volume underwriting in the amount of approximately CHF 900 million.


    Read more: ARYZTA completed a rights offering in the amount of approximately CHF 900 million
  • Amun issues cryptocurrency-linked Exchange Traded Products

    On 13 November 2018, Amun AG, a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully registered its issuance program for the issuance of Exchange Traded Products (ETP) on the SIX Swiss Exchange.


    Read more: Amun issues cryptocurrency-linked Exchange Traded Products
  • Zur Rose Group completed a rights offering in the amount of approximately CHF 190 million

    On 29 November 2018, Zur Rose Group AG, Europe’s largest online pharmacy and one of the leading medical wholesalers in Switzerland, completed its rights issue to support the financing of the medpex acquisition as well as other organic growth initiatives.


    Read more: Zur Rose Group completed a rights offering in the amount of approximately CHF 190 million
  • Rights Offering of ARYZTA

    On 19 November 2018, ARYZTA, a global food business with a leadership position in speciality bakery, completed a capital increase by way of a rights offering structured as a volume underwriting in the amount of approximately CHF 900 million. 97.4% of the shareholders of ARYZTA exercised their subscription rights in the rights offering. The new…


    Read more: Rights Offering of ARYZTA
  • SIG Combibloc Group IPO on SIX Swiss Exchange

    SIG Combibloc Group, a leading provider of aseptic carton packaging solutions for the food and beverage industry, sucessfully priced its IPO and listed its shares on the SIX Swiss Exchange, where trading commenced on 28 September 2018. The offering consisted of a base offering of both new and existing shares and a fully exercised over-allotment…


    Read more: SIG Combibloc Group IPO on SIX Swiss Exchange